CardioComm Solutions, Inc. (TSXV:EKG)
Canada · Delayed Price · Currency is CAD 0.0100
+0.0050 (100.00%)
Sep 18, 2026, 2:16 PM EST
CardioComm Solutions Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.28 | 0.27 | 0.53 | 0.88 | 1 | 0.68 | |
Revenue Growth | -41.89% | -48.33% | -39.91% | -11.99% | 45.90% | -18.24% |
Cost of Revenue | 0.06 | 0.05 | 0.02 | 0.13 | 0.26 | 0.06 |
Gross Profit | 0.22 | 0.22 | 0.51 | 0.75 | 0.74 | 0.62 |
Selling, General & Admin | 0.7 | 0.7 | 0.67 | 0.86 | 0.72 | 0.74 |
Research & Development | - | - | - | - | - | 0.01 |
Operating Expenses | 0.73 | 0.74 | 0.74 | 0.89 | 0.76 | 0.79 |
Operating Income | -0.52 | -0.52 | -0.23 | -0.14 | -0.02 | -0.17 |
Interest Expense | -0.08 | -0.05 | -0.04 | -0.03 | -0.02 | -0.03 |
Currency Exchange Gain (Loss) | -0.02 | 0 | -0 | -0.01 | 0.02 | -0 |
Other Non Operating Income (Expenses) | -0.04 | 0.04 | 0.07 | 0.08 | 0.02 | 0.17 |
EBT Excluding Unusual Items | -0.66 | -0.53 | -0.19 | -0.1 | -0 | -0.04 |
Other Unusual Items | - | - | - | - | - | 0.04 |
Pretax Income | -0.66 | -0.53 | -0.19 | -0.1 | -0 | 0 |
Net Income | -0.66 | -0.53 | -0.19 | -0.1 | -0 | 0 |
Net Income to Common | -0.66 | -0.53 | -0.19 | -0.1 | -0 | 0 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 197 | 195 | 171 | 151 | 151 | 149 |
Shares Outstanding (Diluted) | 197 | 195 | 171 | 151 | 151 | 149 |
Shares Change | 2.58% | 13.82% | 13.27% | 0.22% | 1.12% | 5.46% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.39 | -0.46 | -0.12 | -0.06 | 0.04 | -0.12 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | - | - | -0.00 |
Gross Margin | 76.86% | 81.48% | 96.42% | 85.43% | 74.35% | 90.66% |
Operating Margin | -184.74% | -190.96% | -43.48% | -15.99% | -2.26% | -25.01% |
Profit Margin | -236.02% | -194.55% | -36.94% | -11.11% | -0.25% | 0.04% |
Free Cash Flow Margin | -140.11% | -167.40% | -21.96% | -6.40% | 4.45% | -17.70% |
EBITDA | -0.52 | -0.52 | -0.23 | -0.14 | -0.02 | -0.17 |
EBITDA Margin | -183.84% | -189.77% | -42.92% | -15.57% | -1.75% | -24.36% |
D&A For EBITDA | 0 | 0 | 0 | 0 | 0.01 | 0 |
EBIT | -0.52 | -0.52 | -0.23 | -0.14 | -0.02 | -0.17 |
EBIT Margin | -184.74% | -190.95% | -43.48% | -15.99% | -2.26% | -25.01% |
Revenue as Reported | 0.28 | 0.27 | 0.53 | 0.88 | 1 | 0.68 |